Gotham Asset Management LLC Acquires New Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Gotham Asset Management LLC acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH) in the 4th quarter, HoldingsChannel reports. The institutional investor acquired 44,419 shares of the company’s stock, valued at approximately $1,031,000.

Several other hedge funds have also recently added to or reduced their stakes in OPCH. Murphy & Mullick Capital Management Corp acquired a new position in Option Care Health in the 4th quarter valued at $26,000. UMB Bank n.a. raised its stake in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after purchasing an additional 346 shares during the last quarter. Signaturefd LLC raised its stake in Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after purchasing an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC raised its stake in Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Johnson Financial Group Inc. acquired a new position in Option Care Health in the 4th quarter valued at $47,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.64% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of brokerages have issued reports on OPCH. JPMorgan Chase & Co. raised their target price on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research note on Thursday, March 6th. UBS Group raised Option Care Health from a “neutral” rating to a “buy” rating and raised their target price for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. JMP Securities reaffirmed a “market outperform” rating and issued a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research note on Wednesday, April 30th. Finally, Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $35.50.

Option Care Health Stock Performance

NASDAQ OPCH opened at $33.23 on Friday. The stock has a market cap of $5.44 billion, a PE ratio of 27.92, a P/E/G ratio of 2.30 and a beta of 0.76. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The stock has a fifty day simple moving average of $33.07 and a 200-day simple moving average of $29.02.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.04. The business had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company’s revenue was up 16.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.26 EPS. Equities analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.